Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis ...

Branded therapies drive stronger growth; Generics segment remains foundational business base; Valuation debate shaped by earnings multiples; Teva Pharmaceutical Indust ...

Teva Pharmaceutical Industries Limited ( TEVA) Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDT ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the autoinjector device for AJOVY ® ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Teva Pharmaceutical Industries (NYSE:TEVA) has recently ...

Under its pivot to growth strategy, Teva has expanded its biosimilars portfolio and strengthened its generics business, returning that segment to positive growth. In the latest quarter, Teva exceeded ...

There's nothing generic about this drugmaker's recent performance and continued prospects.

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...

If you are wondering whether Teva Pharmaceutical Industries still represents good value after a strong run, or if you may be ...

Teva Pharmaceutical Industries is a large manufacturer of generic drugs. The company is working to expand into more complex generics and to develop its own drugs. Historically, Teva produced generic ...

Teva Pharmaceutical is a bit of a turnaround story, as the company continues a major business overhaul. This competitor, with a huge 6.3% yield, has hit a few setbacks, but it is still just business ...